Nothing Special   »   [go: up one dir, main page]

Baimukhanova et al., 2022 - Google Patents

An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in …

Baimukhanova et al., 2022

Document ID
17755112232193694236
Author
Baimukhanova A
Engudar G
Marinov G
Kurakina E
Dadakhanov J
Karaivanov D
Yang H
Ramogida C
Schaffer P
Magomedbekov E
Filosofov D
Radchenko V
Publication year
Publication venue
Nuclear Medicine and Biology

External Links

Snippet

Abstract Targeted Alpha Therapy (TAT) has shown very high potential for the treatment of cancers that were not responsive to other therapy options (eg, β− therapy and chemotherapy). The main constraint to the widespread use of TAT in clinics is the limited …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G21G2001/0042—Technetium
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles

Similar Documents

Publication Publication Date Title
Gracheva et al. Production and characterization of no-carrier-added 161 Tb as an alternative to the clinically-applied 177 Lu for radionuclide therapy
McNeil et al. Production, purification, and radiolabeling of the 203 Pb/212 Pb theranostic pair
Lin et al. Production of curie quantities of 68Ga with a medical cyclotron via the 68Zn (p, n) 68Ga reaction
Mikolajczak et al. Radiometals for imaging and theranostics, current production, and future perspectives
Lehenberger et al. The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy
Qaim The present and future of medical radionuclide production
Nelson et al. Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers
Walczak et al. Cyclotron production of 43 Sc for PET imaging
Loveless et al. Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47 Sc
Chakraborty et al. On the practical aspects of large-scale production of 177 Lu for peptide receptor radionuclide therapy using direct neutron activation of 176 Lu in a medium flux research reactor: the Indian experience
Tieu et al. Rapid and automated production of [68Ga] gallium chloride and [68Ga] Ga-DOTA-TATE on a medical cyclotron
Perron et al. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories
Hansen et al. Advancement in production of radiotracers
US20190307909A1 (en) Production of 43sc radionuclide and its use in positron emission tomography
Stevenson et al. Methods of producing high specific activity Sn-117m with commercial cyclotrons
Svedjehed et al. Automated, cassette-based isolation and formulation of high-purity [61 Cu] CuCl 2 from solid Ni targets
Mastren et al. A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
Becker et al. Cyclotron production of 43Sc and 44gSc from enriched 42CaO, 43CaO, and 44CaO targets
Abel et al. Production, collection, and purification of 47Ca for the generation of 47Sc through isotope harvesting at the national superconducting cyclotron laboratory
Baimukhanova et al. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)
Braccini et al. Optimization of 68Ga production at an 18 MeV medical cyclotron with solid targets by means of cross-section measurement of 66Ga, 67Ga and 68Ga
Chakravarty et al. Reactor production and electrochemical purification of 169Er: a potential step forward for its utilization in in vivo therapeutic applications
Chakraborty et al. Feasibility study for production of 175Yb: a promising therapeutic radionuclide
Grundler et al. The metamorphosis of radionuclide production and development at Paul Scherrer Institute
Favaretto et al. Terbium-149 production: a focus on yield and quality improvement towards preclinical application